Yes, shingles can cause hair loss, but it is uncommon and usually temporary. When herpes zoster affects the scalp, inflammation and vesicles can damage hair follicles in the affected dermatome; most shedding begins 2 to 12 weeks after the rash and improves over 3 to 12 months. Permanent scarring hair loss is rare, occurring mainly after severe necrotizing shingles or secondary bacterial infection. The risk is highest when the rash involves the scalp, when treatment starts after 72 hours, and in people over 50 or immunocompromised.
How Scalp Shingles Causes Hair Loss
Herpes zoster is not a new infection. After chickenpox, varicella-zoster virus remains dormant in dorsal root ganglia. Reactivation travels along a sensory nerve and produces a band-like rash in one dermatome. On the scalp, that dermatome may follow the ophthalmic division of the trigeminal nerve or the C2 to C4 cervical nerves. The virus does not directly consume hair shafts; the immune response and local tissue injury cause the damage.
Within the rash, inflammation surrounds the hair follicle and its blood supply. Vesicles can rupture and crust, and scratching can add a bacterial infection. If inflammation is intense, the follicle’s stem-cell region in the bulge can be destroyed. When that region survives, the follicle usually re-enters its normal growth cycle.
Two patterns matter. Localized post-zoster alopecia occurs inside or at the edge of the rash and tracks the affected nerve. Diffuse telogen effluvium can follow any severe illness, including shingles, and appears as widespread shedding. Anagen lasts 2 to 6 years, while telogen lasts about 2 to 3 months, which explains the delay between rash and visible shedding. Diffuse telogen effluvium usually begins 2 to 3 months after severe illness, while localized post-zoster shedding can appear 2 to 12 weeks after the rash.
In plain terms: the scalp rash is the trigger, but the hair fall often appears weeks later because follicles shift into a resting phase before the old hair is pushed out. Normal shedding is about 50 to 100 hairs per day; telogen shedding can exceed 100 hairs daily, though exact counts vary. The key question is whether the follicle remains alive and capable of regrowth.
Can Shingles Cause Hair Loss? The Risk Context
About 1 in 3 people in the United States will develop shingles in their lifetime, per CDC estimates. Most cases involve thoracic dermatomes, so visible scalp hair loss is a subset of a subset. Ophthalmic zoster, which involves the first branch of the trigeminal nerve, accounts for roughly 10% to 20% of zoster cases and can extend onto the forehead and scalp. Cervical zoster can also involve the back of the scalp through C2 to C4.
Population-level incidence of post-zoster alopecia is not well measured. Reports are dominated by small case series, and many describe regrowth within 3 to 12 months. Scarring alopecia after zoster is rarer and is linked to severe necrosis, secondary infection, or delayed antiviral treatment. A reasonable clinical estimate is that temporary shedding is far more common than permanent follicle loss, but no validated percentage applies to every patient.
Risk rises with age. Shingles incidence increases after age 50, and immunosuppression raises risk further. Per the 2018 IDSA guidelines, antiviral treatment should start within 72 hours of rash onset in most patients. That window is a treatment threshold, not a guarantee against hair loss; some patients still shed after prompt therapy.
The scalp is a special site because hair density makes loss visible. A 2 cm patch of alopecia on the scalp is obvious, while a similar area of inflammation on the trunk may leave no cosmetic concern. That visibility can make post-zoster hair loss seem more common than it is. It can also make normal telogen shedding feel more alarming after a painful rash.
Hair Loss Timeline After Shingles
The time course separates normal post-zoster shedding from scarring alopecia. Most temporary loss follows a predictable sequence, but the range is wide. The table below shows the typical stages and the hair outcomes that clinicians look for.
| Stage | Typical timing | What happens | Hair outcome |
|---|---|---|---|
| Rash onset | Days 0 to 3 | Pain and tingling precede vesicles in one dermatome; antiviral window opens | Follicles are exposed to inflammation; visible shedding is not expected |
| Vesicles and crusting | Days 3 to 14 | Vesicles rupture and crust; secondary infection risk rises | Localized follicle injury is possible; shedding is still usually delayed |
| Shedding begins | 2 to 12 weeks after rash | Telogen hairs release; loss may be localized or diffuse | Most temporary shedding starts in this window |
| Early regrowth | 3 to 6 months | Follicles re-enter anagen if the bulge survives | Fine regrowth is common; density may lag behind visible growth |
| Recovery window | 6 to 12 months | Density improves gradually in nonscarring cases | Most temporary cases recover substantially |
| Persistent loss | After 12 months | Scarring or another diagnosis is considered | Permanent loss is possible; dermatology review is warranted |
These thresholds are not competing onset times: the 72-hour antiviral window affects early viral control, shedding can begin 2 to 12 weeks later, recovery is judged over 3 to 12 months, and loss that persists beyond 12 months warrants evaluation for scarring alopecia. A patient can see shedding at week 3 and still recover by month 9; that is within the usual range. Conversely, a rash that healed quickly can still be followed by telogen effluvium.
The timeline also affects treatment decisions. Starting minoxidil at week 2 for expected telogen shedding is usually premature. Waiting 3 months allows the clinician to confirm the pattern and exclude active inflammation. If a smooth hairless patch is already visible at 3 months, earlier trichoscopy may be justified.
Temporary Shedding vs Scarring Alopecia
When patients ask, “Can shingles cause hair loss?” the next question is whether the loss is temporary or scarring. The distinction matters because the treatments and the prognosis are different. Temporary shedding preserves the follicle opening; scarring alopecia destroys it.
| Feature | Temporary post-shingles shedding | Scarring post-shingles alopecia |
|---|---|---|
| Mechanism | Telogen shift or reversible perifollicular inflammation | Destruction of follicular bulge stem cells |
| Pattern | Diffuse loss or localized loss within the dermatome | Localized scarred patch in the rash area |
| Onset | 2 to 12 weeks after rash | Often after severe rash; recognized by 3 to 12 months |
| Scalp signs | No visible scar; follicular openings may remain | Smooth, shiny skin; loss of follicular openings |
| Regrowth chance | High; most improve by 6 to 12 months | Low; destroyed follicles do not regenerate |
| Action | Photo tracking, gentle care, review at 3 months | Dermatology review; trichoscopy or biopsy if uncertain |
The practical distinction is whether follicular openings remain. Temporary shedding leaves the scalp surface intact, even when hair density is low. Scarring alopecia produces a smooth patch with fewer follicular openings. Trichoscopy can show whether follicles are still present, and a scalp biopsy is reserved for uncertain cases.
Numbers help set expectations. Review at 3 months for persistent shedding, at 6 to 12 months for regrowth, and at 12 months for permanent-loss planning. A 1 cm scarred patch may be stable enough for reconstruction later, but ongoing inflammation can destabilize grafts. Most temporary cases do not need surgery at all.
Edge Cases and Misconceptions
Immunosuppression is the strongest modifier. People with HIV, organ transplants, or active chemotherapy can have more extensive zoster, slower crusting, and a higher chance of scarring. Age is another modifier: shingles incidence and severity rise after 50, and postherpetic neuralgia occurs in roughly 10% to 18% of zoster patients, per CDC estimates. That same inflammatory intensity can increase follicular damage when the scalp is involved.
Ophthalmic zoster deserves separate mention. It accounts for about 10% to 20% of zoster cases and can produce vesicles on the forehead, eyelid, and anterior scalp. Eye involvement is urgent because corneal damage can occur; scalp hair loss is secondary to that problem. Cervical dermatomes C2 to C4 can also involve the back of the scalp.
Secondary bacterial infection is a preventable edge case. Crusting, weeping, spreading redness, or fever after day 3 to 5 should prompt review. Scratching and picking increase the chance of follicular destruction. Severe necrotizing zoster is rare but is the clearest route to permanent scarring alopecia.
Several misconceptions persist. Shingles does not usually destroy hair at the moment the rash appears; the common shedding is delayed by the telogen cycle. Antivirals reduce viral replication when started within 72 hours, but they do not guarantee zero hair loss. Hair loss after shingles is not always permanent, and most cases improve within 3 to 12 months.
Can shingles cause hair loss permanently? It can, but only in rare scarring cases. A smooth, shiny patch with no follicular openings is more concerning than diffuse shedding with an intact scalp surface. A person who notices excess hair on the pillow at week 6 should not assume scarring. A person with a stable hairless patch at month 12 needs a different evaluation.
What to Actually Do
The question “can shingles cause hair loss” should not delay treatment when the scalp or eye is involved. Contact a clinician promptly for a painful rash on the scalp, forehead, nose, or eyelid. Ask whether antiviral treatment is appropriate within the 72-hour window. Early treatment limits viral replication and may reduce tissue damage, even though it cannot guarantee hair preservation.
Keep the rash clean and dry, and avoid scratching or picking at crusts. Use gentle shampoo and avoid tight hats or harsh styling during the inflamed phase. Treat pain adequately because poor sleep and stress can worsen the sense of shedding. Photograph the scalp in consistent lighting every 2 to 4 weeks to document change.
See a dermatologist at 3 months if shedding is persistent or a patch is visible. Ask for trichoscopy to check follicular openings. At 12 months, persistent hairless skin should be evaluated for scarring alopecia. Do not start prescription hair-loss treatments without a diagnosis, because minoxidil can cause temporary shedding and takes 4 to 6 months to show benefit.
Seek urgent care for any of these red flags:
- Rash near the eye, nose tip, or eyelid, especially with vision change
- Severe headache, confusion, neck stiffness, or sensitivity to light
- Ear pain, hearing loss, facial droop, vertigo, or severe dizziness
- Widespread rash, high fever, or a weakened immune system
- Spreading redness, pus, swelling, or fever suggesting bacterial infection
- A growing hairless scar or no regrowth after 12 months
Limits of the Evidence
Post-zoster alopecia is understudied. Most evidence comes from case reports and small series, not large randomized trials. That means clinicians cannot give a precise percentage for permanent loss after scalp shingles. The 2 to 12 week shedding window and the 3 to 12 month recovery window are clinical patterns, not fixed rules.
Treatment evidence is also limited. Topical minoxidil has a role in some nonscarring hair loss, but it is not proven to prevent acute post-zoster shedding. It can take 4 to 6 months to show benefit and may cause temporary shedding first. Corticosteroids reduce inflammation in selected zoster complications, yet evidence that they prevent alopecia is weak.
For scarring alopecia, no medication reliably regrows destroyed follicles. Surgical restoration is individualized and is often delayed until the scalp has been stable for 12 months. The best-supported action remains early antiviral treatment for zoster, prompt control of secondary infection, and careful scalp monitoring during the recovery window.